Fetal sex and maternal risk of pre-eclampsia/eclampsia: a systematic review and meta-analysis

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 124, Issue 4, 2017, Pages 553-560

  Jaskolka, D ^a   Retnakaran, R ^a,b,c,d   Zinman, B ^a,b,c,d   Kramer, C K ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Eclampsia; fetal sex; meta analysis; pre eclampsia; systematic review

Indexed keywords

ECLAMPSIA; FETAL SEX; HIGH RISK POPULATION; HUMAN; PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY; PREECLAMPSIA; PREVALENCE; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; FEMALE; FETUS; MALE; MATERNAL HYPERTENSION; META ANALYSIS; PREGNANCY; PROCEDURES; RISK ASSESSMENT; SEX FACTOR;

FEMALE; FETUS; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MALE; PREGNANCY; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84976886995     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.14163     Document Type: Review

References (47)

1. Sheiner E, Levy A, Katz M, Hershkovitz R, Leron E, Mazor M. Gender does matter in perinatal medicine. Fetal Diagn Ther 2004;19:366–9.
2. Di Renzo GC, Rosati A, Sarti RD, Cruciani L, Cutuli AM. Does fetal sex affect pregnancy outcome? Gend Med 2007;4:19–30.
3. Retnakaran R, Kramer CK, Ye C, Kew S, Hanley AJ, Connelly PW, et al. Fetal sex and maternal risk of gestational diabetes mellitus: the impact of having a boy. Diabetes Care 2015;38:844–51.
4. Retnakaran R, Shah B. Fetal sex and the natural history of maternal risk of diabetes during and after pregnancy. J Clin Endocrinol Metab 2015;100:2574–80.
5. Jaskolka D, Retnakaran R, Zinman B, Kramer CK. Sex of the baby and risk of gestational diabetes mellitus in the mother: a systematic review and meta-analysis. Diabetologia 2015;58:2469–75.
6. Toivanen P, Hirvonen T. Sex ratio of newborns: preponderance of males in toxemia of pregnancy. Science 1970;170:187–8.
7. James WH. Sex ratios of offspring and the causes of placental pathology. Hum Reprod 1995;10:1403–6.
8. Aliyu MH, Salihu HM, Lynch O, Alio AP, Marty PJ. Fetal sex and differential survival in preeclampsia and eclampsia. Arch Gynecol Obstet 2012;285:361–5.
9. Makhseed M, Musini VM, Ahmed MA. Association of fetal gender with pregnancy-induced hypertension and pre-eclampsia. Int J Gynaecol Obstet 1998;63:55–6.
10. Hsu CD, Johnson TR, Witter FR. Fetal gender effect on pre-eclampsia: a retrospective study of Baltimore area in the United States of America. Int J Gynaecol Obstet 1994;45:160–1.
11. Shiozaki A, Matsuda Y, Satoh S, Saito S. Impact of fetal sex in pregnancy-induced hypertension and preeclampsia in Japan. J Reprod Immunol 2011;89:133–9.
12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008–12.
13. Kramer CK, Zinman B, Gross JL, Canani LH, Rodrigues TC, Azevedo MJ, et al. Coronary artery calcium score prediction of all cause mortality and cardiovascular events in people with type 2 diabetes: systematic review and meta-analysis. BMJ 2013;346:f1654.
14. Kramer CK, Zinman B, Retnakaran R. Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis. Lancet Diabetes Endocrinol 2013;1:28–34.
15. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med 2013;159:758–69.
16. Eng C, Kramer CK, Zinman B, Retnakaran R. Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis. Lancet 2014;384:2228–34.
17. Wells GASB, O'Connell D, Petersen J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa, Canada. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
18. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603–5.
19. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58.
20. Aibar L, Puertas A, Valverde M, Carrillo MP, Montoya F. Fetal sex and perinatal outcomes. J Perinat Med 2012;40:271–6.
21. Basso O, Olsen J. Sex ratio and twinning in women with hyperemesis or pre-eclampsia. Epidemiology 2001;12:747–9.
22. Campbell DM, MacGillivray I, Carr-Hill R, Samphier M. Fetal sex and pre-eclampsia in primigravidae. Br J Obstet Gynaecol 1983;90:26–7.
23. De Souza SW, John RW, Richards B. Studies on the effect of maternal pre-eclamptic toxaemia on placental weight and on head size and birth weight of the newborn. Br J Obstet Gynaecol 1976;83:292–8.
24. Elsmen E, Kallen K, Marsal K, Hellstrom-Westas L. Fetal gender and gestational-age-related incidence of pre-eclampsia. Acta Obstet Gynecol Scand 2006;85:1285–91.
25. He J, Zhang A, Fang M, Fang R, Ge J, Jiang Y, et al. Methylation levels at IGF2 and GNAS DMRs in infants born to preeclamptic pregnancies. BMC Genom 2013;14:472.
26. Khalil MM, Alzahra E. Fetal gender and pregnancy outcomes in Libya: a retrospective study. Libyan J Med 2013;8:20008.
27. Libby G, Murphy DJ, McEwan NF, Greene SA, Forsyth JS, Chien PW, et al. Pre-eclampsia and the later development of type 2 diabetes in mothers and their children: an intergenerational study from the Walker cohort. Diabetologia 2007;50:523–30.
28. Odegard RA, Vatten LJ, Nilsen ST, Salvesen KA, Austgulen R. Umbilical cord plasma leptin is increased in preeclampsia. Am J Obstet Gynecol 2002;186:427–32.
29. Reynolds SA, Roberts JM, Bodnar LM, Haggerty CL, Youk AO, Catov JM. Newborns of preeclamptic women show evidence of sex-specific disparity in fetal growth. Gend Med 2012;9:424–35.
30. Schjetlein R, Abdelnoor M, Haugen G, Husby H, Sandset PM, Wisloff F. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand 1999;78:191–7.
31. Sharifzadeh F, Kashanian M, Fatemi F. A comparison of serum androgens in pre-eclamptic and normotensive pregnant women during the third trimester of pregnancy. Gynecol Endocrinol 2012;28:834–6.
32. Stark MJ, Clifton VL, Wright IM. Neonates born to mothers with preeclampsia exhibit sex-specific alterations in microvascular function. Pediatr Res 2009;65:292–5.
33. Steier JA, Ulstein M, Myking OL. Human chorionic gonadotropin and testosterone in normal and preeclamptic pregnancies in relation to fetal sex. Obstet Gynecol 2002;100:552–6.
34. Sykes SD, Pringle KG, Zhou A, Dekker GA, Roberts CT, Lumbers ER. Fetal sex and the circulating renin-angiotensin system during early gestation in women who later develop preeclampsia or gestational hypertension. J Hum Hypertens 2014;28:133–9.
35. Troisi R, Potischman N, Roberts JM, Ness R, Crombleholme W, Lykins D, et al. Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 2003;32:455–60.
36. Tuovinen S, Raikkonen K, Pesonen AK, Lahti M, Heinonen K, Wahlbeck K, et al. Hypertensive disorders in pregnancy and risk of severe mental disorders in the offspring in adulthood: the Helsinki Birth Cohort Study. J Psychiatr Res 2012;46:303–10.
37. Vatten LJ, Skjaerven R. Offspring sex and pregnancy outcome by length of gestation. Early Hum Dev 2004;76:47–54.
38. Xiao R, Sorensen TK, Williams MA, Luthy DA. Influence of pre-eclampsia on fetal growth. J Matern Fetal Neonatal Med 2003;13:157–62.
39. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330:565.
40. Hnat MD, Sibai BM, Caritis S, Hauth J, Lindheimer MD, MacPherson C, et al. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol 2002;186:422–6.
41. Lykke JA, Langhoff-Roos J, Sibai BM, Funai EF, Triche EW, Paidas MJ. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension 2009;53:944–51.
42. Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol 2013;28:1–19.
43. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974.
44. Roberts JM, Hubel CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009;30(Suppl A):S32–7.
45. Roberts JM. Pathophysiology of ischemic placental disease. Semin Perinatol 2014;38:139–45.
46. Naeye RL, Demers LM. Differing effects of fetal sex on pregnancy and its outcome. Am J Med Genet Suppl 1987;3:67–74.
47. Stark MJ, Dierkx L, Clifton VL, Wright IM. Alterations in the maternal peripheral microvascular response in pregnancies complicated by pre-eclampsia and the impact of fetal sex. J Soc Gynecol Investig 2006;13:573–8.